Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Samumed divulges Wnt signaling inhibitors

March 23, 2016

Kalytera partners with Ramot for osteogenesis imperfecta treatment research

March 18, 2016

Orphan drug designation granted in Japan for tocilizumab in systemic scleroderma

March 18, 2016

Study results support every-other-month dosing of gerilimzumab for rheumatoid arthritis

March 18, 2016

ProMetic Life Sciences to explore use of PBI-4050 for scleroderma

March 16, 2016

BMS reports data on BMS-986142

March 14, 2016

Phase III data show sarilumab superior to adalimumab in patients with active rheumatoid arthritis

March 11, 2016

Han Wha Pharma and Yang Ji Chemical disclose JAK inhibitors

March 11, 2016

Xencor initiates phase II trials of XmAb-5871 for IgG4-related disease and SLE

March 8, 2016

Corbus to study Resunab for systemic lupus erythematosus

March 8, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
Gensci-134: a long-acting growth hormone receptor agonist fusion protein
BioWorld Science
Gensci-134 (Genescience Pharmaceuticals Co. Ltd.) is a growth hormone receptor (GHR) agonist fusion protein that mimics the biological activity of growth hormone...